2650P Metastasis-directed therapies (MDT) for oligometastatic (OM) and oligoprogressive (OP) Renal Cell Cancer (RCC) patients with extra-lung metastases: The KAIROS study. - Dimino, A.; Rizzo, M.; Fazio, I.; Arcara, C.; Mortellaro, G.; Antonuzzo, L.; Conteduca, V.; Lipari, H.; Sirgiovanni, G.; Inguglia, S.; Algeri, L.; Spinnato, V.; et al. (Annals of Oncology, 2025)